Silver-enhanced in situ hybridisation (SISH) detection assay for HER2 gene status determination in breast carcinoma

被引：0
|
作者：
Patakiouta, F. [1 ]
Koumpanaki, M. [1 ]
Anestakis, D. [1 ]
Zafeiriou, G. [1 ]
Paraskevopoulos, P. [1 ]
Papakotoulas, P. [1 ]
Papazisis, T. K. [1 ]
Bousoulegas, A. [1 ]
机构：
[1] Theagen Canc Hosp Thessaloniki, Thessaloniki, Greece
来源：
VIRCHOWS ARCHIV | 2009年 / 455卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [31] Assessment of HER2 Gene Status in Breast Cancer by Dual-color Silver-enhanced in situ Hybridization and its Concordance with FISH Test
    Zhu, Yifei
    Li, Ming
    Lv, Hong
    Bai, Qianming
    Zhou, Xiaoyan
    Yang, Wentao
    LABORATORY INVESTIGATION, 2025, 105 (03)
  • [32] Comparison of HER2 status determination methods: Fluorescent in Situ Hybridization (FISH) vs. dual silver enhanced in Situ Hybridization (SISH)
    Pehlivanoglu, B.
    Zekioglu, O.
    Yeniay, L.
    Yilmaz, R.
    Gokmen, E.
    Ozdemir, N.
    VIRCHOWS ARCHIV, 2016, 469 : S51 - S51
  • [33] Study of the Reproducibility of Silver In-situ Hybridisation for the Assessment of HER2 Status in Breast Cancer
    Lawes, K.
    Bagwan, I.
    Haagsma, B.
    Jackson, P.
    Di Palma, S.
    JOURNAL OF PATHOLOGY, 2012, 226 : S12 - S12
  • [34] Comparison of HER2 status determination methods in HER2 (2+) patients: Manual fluorescent in situ hybridization (FISH) vs. dual silver enhanced in situ hybridization (SISH)
    Pehlivanoglu, Burcin
    Serin, Gurdeniz
    Yeniay, Levent
    Zekioglu, Osman
    Gokmen, Erhan
    Ozdemir, Necmettin
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 31 : 36 - 40
  • [35] SILVER-ENHANCED IN SITU HYBRIDIZATION AS AN ALTERNATIVE TO FLUORESCENCE IN SITU HYBRIDIZATION FOR ASSAYING HER2 AMPLIFICATION IN CLINICAL BREAST CANCER
    Han, S.
    Kim, J. S.
    Gwak, G.
    Park, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 29 - 29
  • [36] Her2 gene status in breast"in situ" and invasive ductal carcinoma
    Cozaru, G. C.
    Mitroi, A. F.
    Aschie, M.
    Brinzan, C. S.
    Poinareanu, I.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 968 - 969
  • [37] Assessment of HER2 status in breast cancer by fluorescence in situ hybridisation
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 235 - 236
  • [38] HER2 Status in Gastric Adenocarcinomas Assessed by Immunohistochemistry, Automated Silver-Enhanced In Situ Hybridization and Fluorescence In Situ Hybridization
    Kim, Aeri
    Bae, Jung Min
    Kim, Se Won
    Gu, Mi Jin
    Bae, Young Kyung
    KOREAN JOURNAL OF PATHOLOGY, 2010, 44 (05) : 493 - 501
  • [39] Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer
    Park, Kyeongmee
    Han, Sehwan
    Kim, Jung-Yeon
    Kim, Hyun-Jung
    Kwon, Ji Eun
    Gwak, Geumhee
    JOURNAL OF BREAST CANCER, 2011, 14 (04) : 276 - 282
  • [40] HER2 STATUS IN OPERABLE BREAST CANCERS FROM VIETNAMESE WOMEN: ANALYSIS BY IMMUNOHISTOCHEMISTRY (IHC) AND AUTOMATED SILVER ENHANCED IN SITU HYBRIDIZATION (SISH)
    Vu, T. H.
    Tani, E.
    Ta, V. T.
    Krawiec, K.
    Skoog, L.
    ANNALS OF ONCOLOGY, 2011, 22 : 38 - 38
12345